… in estrogen receptor–positive breast cancer].” Jian Zhang, MD, … 47;HER2-negative advanced breast cancer, the combination demonstrated … SIM0270 plus everolimus vs exemestane (Aromasin) plus everolimus in … 47;HER2-negative advanced breast cancer after prior CDK4…

… et al; acelERA Breast Cancer Study Investigators. Giredestrant … , previously treated advanced breast cancer: results from the … breast cancer (BC): phase III study of giredestrant + everolimus vs exemestane … Guidelines in Oncology. Breast cancer, version 3.2025 …

… /HER2-negative breast cancers with very small ( … elderly patients with breast cancer. The Breast Cancer Index (BCI) … Adjuvant exemestane with ovarian suppression in premenopausal breast cancer: long … T1a/bN0M0 breast cancer. Breast Cancer Res Treat. 2023 …

… , letrozole, and exemestane block the estrogen … commonly, women with breast cancer who experienced early … breast cancer. Presented at the 2025 Miami Breast Cancer Conference … in hormone-sensitive breast cancer. Living Beyond Breast Cancer. News release …

… ERBB2)–negative metastatic breast cancer who progressed following … ERBB2-negative metastatic breast cancer progress following first … therapy (everolimus plus exemestane or endocrine therapy … ERBB2-negative metastatic breast cancer progressing during endocrine …

… recurrent or metastatic breast cancer previously treated with … endocrine-resistant metastatic breast cancer, the overall response … recurrent or metastatic breast cancer not amenable to … therapy, including anastrozole, exemestane, fulvestrant, letrozole, or …

… ER)–positive, HER2-negative advanced breast cancer regardless of ESR1 mutation status … positive, HER2-negative advanced breast cancer who had either experienced disease … with fulvestrant (Faslodex) or exemestane (Aromasin), or imlunestrant plus abemaciclib. …

… for patients with breast cancer, ultimately improving cure … anastrozole (Arimidex), and exemestane (Aromasin). The trial’s … , HER2-negative breast cancer, adequate organ function … multicentric breast cancer, prior ipsilateral invasive breast cancer, evidence …

… breast cancers (particularly on the same side of the family), early-onset breast cancer (breast cancer … for breast cancer due to family history demonstrating that more breast cancers were … profile. Both aromatase inhibitors (AIs)—exemestane (25 mg daily for 3 …

… immunohistochemistry (IHC) 0 breast cancer. Received lumpectomy and sentinel … She then received exemestane plus everolimus for 6 … HR-positive, HER2-negative breast cancer? Laura Huppert, MD … negative breast cancer, as well as triple-negative breast cancer with …